Correspondence 0001140361-23-049323 from GYRE THERAPEUTICS, INC. (GYRE) (CIK 0001124105) (GYRE)
GYRE THERAPEUTICS, INC. (GYRE) (CIK 0001124105)
Date: Oct. 24, 2023 · CIK: 0001124105 · Accession: 0001140361-23-049323
AI Filing Summary & Sentiment
File numbers found in text: 333-273395
Letter
October 24, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention:
Jason Drory and Laura Crotty
Re:
Catalyst Biosciences, Inc.
Registration Statement on Form S-3 (File No. 333-273395)
Ladies and Gentlemen:
Catalyst Biosciences, Inc. hereby respectfully requests that, pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the effectiveness of the above-referenced Registration Statement on Form S-3 be accelerated so that it will become effective on October 27, 2023, at 9:00 a.m., Eastern Time, or as soon as practicable thereafter, unless we or our outside counsel, Orrick, Herrington & Sutcliffe LLP, request by telephone that such Registration Statement be declared effective at some other time.
We request that we be notified of such effectiveness by a telephone call to Stephen Thau of Orrick, Herrington & Sutcliffe LLP at (212) 506-5076.
Sincerely,
CATALYST BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
October 24, 2023
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549
Attention:
Jason Drory and Laura Crotty
Re:
Catalyst Biosciences, Inc.
Registration Statement on Form S-3 (File No. 333-273395)
Ladies and Gentlemen:
Catalyst Biosciences, Inc. hereby respectfully requests that, pursuant to Rule 461 promulgated under the Securities
Act of 1933, as amended, the effectiveness of the above-referenced Registration Statement on Form S-3 be accelerated so that it will become effective on October 27, 2023, at 9:00 a.m., Eastern Time, or as soon as practicable thereafter, unless we
or our outside counsel, Orrick, Herrington & Sutcliffe LLP, request by telephone that such Registration Statement be declared effective at some other time.
We request that we be notified of such effectiveness by a telephone call to Stephen Thau of Orrick, Herrington &
Sutcliffe LLP at (212) 506-5076.
Sincerely,
CATALYST BIOSCIENCES, INC.
By:
/s/ Nassim Usman
Nassim Usman, Ph.D.
President and Chief Executive Officer
cc:
Stephen Thau, Orrick, Herrington & Sutcliffe LLP